<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK100239" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK100239/" /><meta name="ncbi_pagename" content="CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/10/05" /><meta name="citation_author" content="Christina Sundal" /><meta name="citation_author" content="Zbigniew K Wszolek" /><meta name="citation_pmid" content="22934315" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK100239/" /><meta name="citation_keywords" content="CSF1R-Related ALSP" /><meta name="citation_keywords" content="ALSP" /><meta name="citation_keywords" content="Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS)" /><meta name="citation_keywords" content="Pigmentary Orthochromatic Leukodystrophy (POLD)" /><meta name="citation_keywords" content="Macrophage colony-stimulating factor 1 receptor" /><meta name="citation_keywords" content="CSF1R" /><meta name="citation_keywords" content="CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Christina Sundal" /><meta name="DC.Contributor" content="Zbigniew K Wszolek" /><meta name="DC.Date" content="2017/10/05" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK100239/" /><meta name="description" content="CSF1R-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is characterized by executive dysfunction, memory decline, personality changes, motor impairments, and seizures. A frontal lobe syndrome (e.g., loss of judgment, lack of social inhibitors, lack of insight, and motor persistence) usually appears early in the disease course. The mean age of onset is usually in the fourth decade. Affected individuals eventually become bedridden with spasticity and rigidity. The disease course ranges from two to 30 or more years (mean: 8 years)." /><meta name="og:title" content="CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia" /><meta name="og:type" content="book" /><meta name="og:description" content="CSF1R-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is characterized by executive dysfunction, memory decline, personality changes, motor impairments, and seizures. A frontal lobe syndrome (e.g., loss of judgment, lack of social inhibitors, lack of insight, and motor persistence) usually appears early in the disease course. The mean age of onset is usually in the fourth decade. Affected individuals eventually become bedridden with spasticity and rigidity. The disease course ranges from two to 30 or more years (mean: 8 years)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK100239/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/hdls/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK100239/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88147FE04109D100000000048401AF.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK100239_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK100239_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/col4a1-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/caffey/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK100239_"><span class="title" itemprop="name"><i>CSF1R-</i>Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: <i>CSF1R</i>-Related ALSP</div><p class="contrib-group"><span itemprop="author">Christina Sundal</span>, MD, PhD and <span itemprop="author">Zbigniew K Wszolek</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK100239_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK100239_ai__"><div class="contrib half_rhythm"><span itemprop="author">Christina Sundal</span>, MD, PhD<div class="affiliation small">Department of Neuroscience and Physiology<br />Sahlgrenska Academy<br />Gothenburg University</div><div class="affiliation small">Department of Neurology<br />Aleris Private Hospital<br />Aleris AB<br />Gothenburg, Sweden<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="es.ug.oruen@ladnus.anitsirhc" class="oemail">es.ug.oruen@ladnus.anitsirhc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Zbigniew K Wszolek</span>, MD<div class="affiliation small">Department of Neurology<br />Mayo Clinic<br />Jacksonville, Florida<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.oyam@weingibz.kelozsw" class="oemail">ude.oyam@weingibz.kelozsw</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 30, 2012</span>; Last Update: <span itemprop="dateModified">October 5, 2017</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="hdls.Summary" itemprop="description"><h2 id="_hdls_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>CSF1R</i>-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is characterized by executive dysfunction, memory decline, personality changes, motor impairments, and seizures. A frontal lobe syndrome (e.g., loss of judgment, lack of social inhibitors, lack of insight, and motor persistence) usually appears early in the disease course. The mean age of onset is usually in the fourth decade. Affected individuals eventually become bedridden with spasticity and rigidity. The disease course ranges from two to 30 or more years (mean: 8 years).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis is suspected in individuals with characteristic clinical and brain MRI findings and is confirmed by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CSF1R</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Supportive management includes: attention to general care and nutritional requirements; antiepileptic drugs for seizures; and antibiotic treatment for general and recurrent infections.</p><p><i>Prevention of secondary complications:</i> Information about and support systems for the social problems and suicidal tendencies often associated with disease progression.</p><p><i>Surveillance:</i> Periodic brain MRI and clinical evaluation to monitor disease progression.</p><p><i>Agents/circumstances to avoid:</i> Use of first-generation neuroleptics due to increased seizure risk and risk of additional parkinsonian signs; medications used to treat multiple sclerosis as they are of no benefit and have major side effects.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>CSF1R-</i>related ALSP is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Individuals with <i>CSF1R-</i>related ALSP usually have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> mutation can occur. Each child of an individual with <i>CSF1R-</i>related ALSP has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal testing is possible if the pathogenic variant in a family is known.</p></div></div><div id="hdls.Diagnosis"><h2 id="_hdls_Diagnosis_">Diagnosis</h2><div id="hdls.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>CSF1R</i>-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) <b>should be suspected</b> in individuals with the following clinical and brain findings.</p><p><b>Clinical</b></p><ul><li class="half_rhythm"><div>Progressive neurologic decline; presenting signs may include the following:</div><ul><li class="half_rhythm"><div>Personality changes, cognitive impairments, memory decline, and depression</div></li><li class="half_rhythm"><div>Motor impairments including paresis, gait dysfunction, bradykinesia, rigidity, and tremor</div></li><li class="half_rhythm"><div>On rare occasions, seizures</div></li></ul><div>Later signs usually include dementia, seizures, and pyramidal and extrapyramidal signs.</div></li><li class="half_rhythm"><div>Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance</div></li></ul><p><b>Brain</b></p><ul><li class="half_rhythm"><div><b>On MRI</b> [<a class="bk_pop" href="#hdls.REF.van_gerpen.2008.925">Van Gerpen et al 2008</a>, <a class="bk_pop" href="#hdls.REF.sundal.2012b.566">Sundal et al 2012b</a>, <a class="bk_pop" href="#hdls.REF.bender.2014.2351">Bender et al 2014</a>, <a class="bk_pop" href="#hdls.REF.konno.2014.139">Konno et al 2014</a>, <a class="bk_pop" href="#hdls.REF.konno.2017.37">Konno et al 2017</a>]</div><ul><li class="half_rhythm"><div>The white matter lesions are hyperintense on T<sub>2</sub>-weighted and FLAIR images, and hypointense on T<sub>1</sub>-weighted images.</div></li><li class="half_rhythm"><div>Bifrontal or bifrontoparietal T<sub>2</sub>-weighted/FLAIR hyperintensities in the deep, subcortical, and periventricular areas are typical. The white matter lesions are often asymmetric, especially in the early stages of the disease. Early lesions are patchy and focal, but with time become confluent. T<sub>2</sub>-weighted and FLAIR hyperintensities are present in other areas, including the corpus callosum and corticospinal tracts.</div></li><li class="half_rhythm"><div>Cerebral atrophy manifesting as enlarged ventricles is typical, as is cerebral atrophy corresponding to the white matter lesions.</div></li><li class="half_rhythm"><div>The following are absent:</div><ul><li class="half_rhythm"><div>Significant gray matter pathology</div></li><li class="half_rhythm"><div>Brain stem atrophy</div></li><li class="half_rhythm"><div>Contrast uptake in the parenchyma</div></li></ul></li><li class="half_rhythm"><div>Cerebellar abnormalities are minimal.</div></li></ul></li><li class="half_rhythm"><div><b>On CT.</b> Brain calcifications in the white matter are seen in up to half of individuals. Frequently they have a characteristic pattern of &#x0201c;stepping stone appearance&#x0201d; in the frontal pericallosal area, and punctate appearance in the frontal white matter adjacent to the anterior horns of the lateral ventricles and the parietal subcortical white matter [<a class="bk_pop" href="#hdls.REF.konno.2017.37">Konno et al 2017</a>].</div></li></ul></div><div id="hdls.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>CSF1R</i>-related ALSP <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CSF1R</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK100239/table/hdls.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="fighdlsTmoleculargenetictestingusedin" rid-ob="figobhdlsTmoleculargenetictestingusedin">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>CSF1R</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CSF1R</i> and other genes of interest (see <a href="#hdls.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="hdls.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>CSF1R</i>-Related ALSP</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK100239/table/hdls.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hdls.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hdls.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_hdls.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_hdls.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_hdls.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CSF1R</i></td><td headers="hd_h_hdls.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_hdls.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_hdls.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a href="https://www.ncbi.nlm.nih.gov/books/n/gene/glossary/def-item/duplication/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">duplication</a> analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_hdls.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None detected</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="hdls.TF.1.1"><p class="no_margin">See <a href="/books/n/gene/shortname/#shortname.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="hdls.TF.1.2"><p class="no_margin">See <a href="#hdls.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="hdls.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="hdls.TF.1.4"><p class="no_margin">To date more than 50 pathogenic variants have been reported, including deletions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants. Almost all pathogenic variants are located in the intracellular tyrosine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of exons 12-22 of <i>CSF1R</i> (see <a href="#hdls.Molecular_Genetics">Molecular Genetics</a>).</p></div></dd><dt>5. </dt><dd><div id="hdls.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="hdls.Clinical_Characteristics"><h2 id="_hdls_Clinical_Characteristics_">Clinical Characteristics</h2><div id="hdls.Clinical_Description"><h3>Clinical Description</h3><p><i>CSF1R-</i>related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is characterized by a constellation of findings including executive dysfunction, memory decline, personality changes, motor impairments, and seizures. A frontal lobe syndrome (including loss of judgment, lack of social inhibitors, lack of insight, and motor persistence) usually appears early in the disease course.</p><p>The presenting problems and rate of progression vary among individuals and even within a family harboring the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The mean age of onset is usually in the fourth decade, but ranges from early adulthood to the eighth decade of life [<a class="bk_pop" href="#hdls.REF.sundal.2012b.566">Sundal et al 2012b</a>]. The disease course may be from two to 30 years or more with a mean of eight years.</p><p>Signs and symptoms that usually occur during the disease course include the following:</p><ul><li class="half_rhythm"><div>Personality problems, memory decline, executive dysfunction</div></li><li class="half_rhythm"><div>Disturbances of higher cortical function such as motor aphasia, agraphia, acalculia, and apraxia</div></li><li class="half_rhythm"><div>Depression</div></li><li class="half_rhythm"><div>Gait disturbance</div></li><li class="half_rhythm"><div>Pyramidal signs such as spasticity, hyperreflexia, extensor plantar response, hemiparesis, or quadriparesis</div></li><li class="half_rhythm"><div>Sensory deficits including some impairment of vibration, position, tactile, and pain perception. The higher integrative sensory functions such as graphesthesia, stereognosis, and double simultaneous stimulation are also impaired.</div></li><li class="half_rhythm"><div>Parkinsonian signs such as rigidity, bradykinesia, tremor (resting and/or kinetic), shuffling gait, and postural instability. Hypomimic face and hypophonic voice are common. Lack of beneficial response to levodopa defines the parkinsonian signs as atypical.</div></li><li class="half_rhythm"><div>Bulbar/pseudobulbar signs: dysphagia, dysarthria, slurred speech, and palatal myoclonus</div></li><li class="half_rhythm"><div>Cerebellar signs with ataxia, dysmetria, and intention tremor</div></li><li class="half_rhythm"><div>Visual field defects such as homonymous quadrantanopsia or hemianopsia</div></li><li class="half_rhythm"><div>Other signs of a movement disorder: dystonia, myoclonic twitches, dyskinesia, and akathisia</div></li><li class="half_rhythm"><div>Seizures in some individuals (at times only a single episode at the onset of the illness)</div></li><li class="half_rhythm"><div>Progressive course</div></li></ul><p>Affected individuals eventually become bedridden with spasticity and rigidity. They lose speech and voluntary movements, and appear to be generally unaware of their surroundings. In the last stage of the disease, individuals lose their ability to walk and progress to a vegetative state. Primitive reflexes, such as visual and tactile grasp and mouth-opening reflex, as well as the sucking reflex, are present.</p><p>Death most commonly results from pneumonia or other infections.</p><p><b>Other findings.</b> Cerebrospinal fluid (CSF):</p><ul><li class="half_rhythm"><div>Normal cell count, glucose concentration, and proteins</div></li><li class="half_rhythm"><div>No inflammatory cells</div></li><li class="half_rhythm"><div>Usually normal <a class="def" href="/books/n/gene/glossary/def-item/isoelectric-focusing/">isoelectric focusing</a> and no oligoclonal bands; however, oligoclonal bands have been demonstrated in samples from <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK100239/table/hdls.T.csf1r_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="fighdlsTcsf1rpathogenicvariantsdiscuss" rid-ob="figobhdlsTcsf1rpathogenicvariantsdiscuss">p.Asn854Lys</a> or <a class="figpopup" href="/books/NBK100239/table/hdls.T.csf1r_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="fighdlsTcsf1rpathogenicvariantsdiscuss" rid-ob="figobhdlsTcsf1rpathogenicvariantsdiscuss">p.Val 838Leu</a> [<a class="bk_pop" href="#hdls.REF.karle.2013.2039">Karle et al 2013</a>, <a class="bk_pop" href="#hdls.REF.levin.2014.113">Levin et al 2014</a>, <a class="bk_pop" href="#hdls.REF.schuberth.2014.465">Schuberth et al 2014</a>, <a class="bk_pop" href="#hdls.REF.sundal.2015.328">Sundal et al 2015</a>].</div></li><li class="half_rhythm"><div>No identified CSF biomarker. The following preliminary findings in four persons with ALSP need to be interpreted cautiously and require further research [<a class="bk_pop" href="#hdls.REF.sundal.2012a.67">Sundal et al 2012a</a>, <a class="bk_pop" href="#hdls.REF.sundal.2015.328">Sundal et al 2015</a>]:</div><ul><li class="half_rhythm"><div>Normal A&#x003b2;42 protein concentrations</div></li><li class="half_rhythm"><div>Minimally increased levels of total Tau protein concentrations</div></li><li class="half_rhythm"><div>Borderline normal phospho-Tau protein concentrations</div></li><li class="half_rhythm"><div>Elevated neurofilament light chain (NF-L) proteins (Note that NF-L proteins are markers of neuronal death and axonal damage.)</div></li><li class="half_rhythm"><div>Slight increase in glial fibrillary acidic protein, indicating gliosis or astroglial cell damage</div></li></ul></li></ul><p><b>Brain pathology.</b> The following features may be seen on brain biopsy or at autopsy:</p><ul><li class="half_rhythm"><div>White matter changes that are typically vacuolated and demyelinated</div></li><li class="half_rhythm"><div>Axonal spheroids in the white matter lesions that are immunoreactive for neurofilament, amyloid precursor protein, and ubiquitin</div></li><li class="half_rhythm"><div>Bizarre astrocytes and lipid-laden and myelin-laden macrophages</div></li><li class="half_rhythm"><div>Unaffected or very mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> basal ganglia, thalamus, hypothalamus, hippocampus, substantia nigra, raphe nucleus, reticular formation, and cerebellar gray matter</div></li><li class="half_rhythm"><div>Absence or only traces of amyloid angiopathy in parenchymal or leptomeningeal vessels</div></li><li class="half_rhythm"><div>Pigmented changes of either iron or lipofuscin found in macrophages and other glia cells</div></li></ul></div><div id="hdls.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation exists: individuals from the same family harboring the same <i>CSF1R</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> do not necessarily share the same phenotype. In the end stage all have devastating multiple neurologic impairments.</p></div><div id="hdls.Penetrance"><h3>Penetrance</h3><p>Penetrance appears to be incomplete [<a class="bk_pop" href="#hdls.REF.karle.2013.2039">Karle et al 2013</a>, <a class="bk_pop" href="#hdls.REF.sundal.2015.328">Sundal et al 2015</a>, <a class="bk_pop" href="#hdls.REF.konno.2017.37">Konno et al 2017</a>]; estimates have not been calculated given the limited number of families reported to date. Although <i>CSF1R-</i>related ALSP is a dominantly inherited disease, <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> mutation occurs and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> in terms of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and the disease course can be found in members of the same family sharing the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="hdls.Nomenclature"><h3>Nomenclature</h3><p>Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is within the same disease spectrum as <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pigmentary orthochromatic leukodystrophy (POLD) [<a class="bk_pop" href="#hdls.REF.wider.2009.1953">Wider et al 2009</a>]. Because of the phenotypic and radiologic similarities of the two disorders, <a class="bk_pop" href="#hdls.REF.wider.2009.1953">Wider et al [2009]</a> proposed the following terminology for the combined entity: "adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)." Families with POLD have recently been found to have <i>CSF1R</i> pathogenic variants [<a class="bk_pop" href="#hdls.REF.nicholson.2013.1033">Nicholson et al 2013</a>], providing evidence that HDLS and POLD are a single disease entity. Because a similar <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has been reported in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>AARS2</i> pathogenic variants, the authors propose new nomenclature: <i>CSF1R</i>-related ALSP.</p></div><div id="hdls.Prevalence"><h3>Prevalence</h3><p><i>CSF1R</i>-related ALSP was previously thought to be a rare disease. However, recent expanded publications in this field have demonstrated that it is more common than previously recognized: it is now estimated to be responsible for 10%-25% of adult-onset leukodystrophy. However, actual prevalence figures have not been reported [<a class="bk_pop" href="#hdls.REF.lynch.2016.512">Lynch et al 2016</a>].</p></div></div><div id="hdls.Genetically_Related_Allelic_Disorde"><h2 id="_hdls_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those described in this <i>GeneReview</i> have been associated with mutation of <i>CSF1R.</i></p></div><div id="hdls.Differential_Diagnosis"><h2 id="_hdls_Differential_Diagnosis_">Differential Diagnosis</h2><p>The clinical presentation of <i>CSF1R</i>-related ALSP often overlaps with other neurologic disorders. <i>CSF1R-</i>related ALSP should be considered in previously healthy individuals who develop cognitive decline, memory problems, and personality changes in midlife with a progressive course and white matter lesions evident on brain MRI.</p><p>Because the signs and symptoms in the early stages of <i>CSF1R-</i>related ALSP are nonspecific, ALSP can often be confused with the inherited and <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> disorders listed below. In individuals with <i>CSF1R-</i>related ALSP, laboratory and/or genetic testing for these other disorders are normal.</p><div id="hdls.T.disorders_to_consider_in_the_diff" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>CSF1R</i>-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK100239/table/hdls.T.disorders_to_consider_in_the_diff/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hdls.T.disorders_to_consider_in_the_diff_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3" id="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>CSF1R</i>-Related ALSP</th><th headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3" id="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>CSF1R</i>-Related ALSP</th></tr></thead><tbody><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Autosomal dominant disorders</b></td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alexander/">Alexander disease</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GFAP</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bulbar/pseudobulbar signs, ataxia, spasticity</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Palatal myoclonus; cognitive function in adults frequently normal; infratentorial atrophy on MRI</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adult-onset <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> leukodystrophy (OMIM <a href="http://omim.org/entry/169500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">169500</a>)</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMNB1</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment, pyramidal &#x00026; cerebellar signs</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early autonomic dysfunction; a periventricular normal rim on MRI</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cadasil/">CADASIL</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NOTCH3</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontal lobe syndrome, WML</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Stroke-like clinical signs; multiple cerebral infarcts &#x00026; WML incl the characteristic temporal pools</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MAPT</i>-related disorders (OMIM <a href="http://omim.org/entry/157140" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">157140</a>)</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MAPT</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progresses over a few years into profound dementia w/mutism</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontal &#x00026;/or temporal atrophy w/far fewer WML</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ftd-chmp2b/">Frontotemporal dementia, chromosome 3-linked</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHMP2B</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontal lobe <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; pyramidal &#x00026;/or extrapyramidal signs</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontal &#x00026;/or temporal atrophy w/far fewer WML</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ftd-grn/"><i>GRN</i>-related frontotemporal dementia</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GRN</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontal lobe <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; pyramidal/extrapyramidal signs</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontal &#x00026;/or temporal atrophy w/far fewer WML</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/als-ftd/"><i>C9orf72</i>-related FTD</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C9orf72</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontal lobe <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; pyramidal/extrapyramidal signs</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontal &#x00026;/or temporal atrophy w/far fewer WML</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alzheimer/">Early-onset Alzheimer disease</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>APP</i>, <i>PSEN1</i>, <i>PSEN2</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Executive dysfunction &#x00026; personality changes; similar onset age</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Episodic memory loss; WM changes present but much less pronounced</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Autosomal recessive disorders</b></td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/plosl/">PLOSL</a> (Nasu-Hakola disease)</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TREM2</i>, <i>TYROBP</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Insidious personality changes, frontal lobe syndrome, motor impairments, dementia &#x00026; progression to vegetative stage</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pain/tenderness of feet/wrists, polycystic osseous lesions, pathologic fractures; U-fibers partially <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a></td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cach/">Vanishing white matter</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B1</i>, <i>EIF2B2</i>, <i>EIF2B3</i>, <i>EIF2B4</i>, <i>EIF2B5</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive decline, spastic paraparesis, cerebellar ataxia</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Stress-induced deterioration w/minor trauma or infections; more widespread &#x00026; diffuse WM changes &#x00026; atrophy than in ALSP; cystic breakdown of the WM</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adult type of <a href="/books/n/gene/mld/">metachromatic leukodystrophy</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARSA</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Executive dysfunction, personality changes, memory problems, pyramidal signs and seizures</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peripheral neuropathy; spread of WML into the cerebellar region &#x00026; WM myelin breakdown w/low-density tigroid stripes</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adult form of <a href="/books/n/gene/krabbe/">Krabbe disease</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GALC</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pyramidal signs, developing into para- or tetraparesis</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peripheral neuropathy; MRI w/predominance in the posterior part of the WM. MRI detects demyelination in the brain stem &#x00026; cerebellum. T<sub>2</sub>-weighted value is progressively prolonged in the occipital deep WM and posterior part of central semiovale in late-onset disease.</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lbsl/">LBSL</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DARS2</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slowly progressive pyramidal, cerebellar, &#x00026; dorsal column dysfunction; deterioration of motor skills</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peripheral neuropathy; WML are either non-homogeneous/spotty or homogeneous &#x00026; confluent. Signal abnormalities are evident in the medullary pyramids, dorsal columns, &#x00026; lateral corticospinal tracts.</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AARS2-</i>related ALSP</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AARS2</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive, neuropsychiatric, &#x00026; upper motor neuron signs; symmetric leukoencephalopathy w/punctate regions of restricted diffusion</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Earlier age of onset of symptoms (mean age 26 yrs); ovarian failure in all women. WM demonstrates rarefaction [<a class="bk_pop" href="#hdls.REF.lakshmanan.2017.e135">Lakshmanan et al 2017</a>].</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorders</b></td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCD1</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive decline, dementia, spastic paraparesis</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropathy &#x00026; slowly spastic paraparesis. WML are contrast enhancing. Corticospinal tracts are involved from cranial to medulla.</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fabry/">Fabry disease</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GLA</i></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">WML</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gray matter pathology</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Mitochondrial disorders (caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA)</b></td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kss/">Leigh syndrome</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">mtDNA <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Psychomotor regression; WML may be present in adult mt diseases</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Strikingly different clinical presentation; brain MRI in mt diseases may demonstrate symmetric T<sub>1</sub>-weighted hypointense &#x00026; T<sub>2</sub>-weighted hyperintense signal abnormalities in deep gray matter; abnormalities are not restricted to vascular territories; lesions often fluctuate over the course of the disease. Varying degrees of cerebral &#x00026; cerebellar atrophy may also be present.</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/melas/">MELAS</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TL1</i> or other mtDNA genes</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/">Alpers-Huttenlocher syndrome</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLG</i>&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mngie/">MNGIE</a></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TYMP</i>&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Other (complex <a class="def" href="/books/n/gene/glossary/def-item/multifactorial/">multifactorial</a> inheritance/<a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a>)</b></td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Primary progressive multiple sclerosis (PPMS)</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">WML</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive decline occurs later; callosomarginal lesions occur.<br />Confluent WML in frontoparietal areas are more consistent w/<i>CSF1R</i>-related ALSP than w/PPMS&#x000a0;<sup>2</sup>.</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Susac syndrome</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment, behavioral changes</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Branch retinal artery inclusions, tinnitus, hearing loss, vertigo; gray matter lesions</td></tr><tr><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontotemporal lobar degeneration</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The combination of FTD &#x00026; atypical parkinsonism is characterized by multisystem atrophy &#x00026; progressive supranuclear palsy; the addition of ALS can mimic clinical ALSP.</td><td headers="hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_1_3 hd_h_hdls.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI demonstrates mainly cerebral atrophy w/out the characteristic WML found in <i>CSF1R</i>-related ALSP.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ALS = amyotrophic lateral sclerosis; CADASIL = <i>c</i>erebral <i>a</i>utosomal <i>d</i>ominant <i>a</i>rteriopathy with <i>s</i>ubcortical <i>i</i>nfarcts and <i>l</i>eukoencephalopathy; FTD = frontotemporal dementia; LBSL = leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation; MELAS = <i>m</i>itochondrial <i>e</i>ncephalomyopathy, <i>l</i>actic <i>a</i>cidosis, and <i>s</i>troke-like episodes; MNGIE = <i>m</i>itochondrial <i>n</i>euro<i>g</i>astro<i>i</i>ntestinal <i>e</i>ncephalopathy; PLOSL = <i>p</i>olycystic <i>l</i>ipomembranous <i>o</i>steodysplasia with <i>s</i>clerosing <i>l</i>eukoencephalopathy; WM = white matter; WML = white matter lesions</p></div></dd><dt>1. </dt><dd><div id="hdls.TF.2.1"><p class="no_margin">Alpers-Huttenlocher syndrome and MNGIE are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div></dd><dt>2. </dt><dd><div id="hdls.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#hdls.REF.sundal.2015.328">Sundal et al [2015]</a></p></div></dd></dl></div></div></div></div><div id="hdls.Management"><h2 id="_hdls_Management_">Management</h2><div id="hdls.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with <i>CSF1R</i>-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Complete neurologic assessment</div></li><li class="half_rhythm"><div>Psychological and psychiatric assessments</div></li><li class="half_rhythm"><div>Brain MRI to determine the extent and localization of white matter changes, presence of cortical atrophy, and involvement of the corpus callosum and corticospinal tracts</div></li><li class="half_rhythm"><div>Assessment of feeding/eating, digestive problems (constipation, incontinence), and nutrition based on clinical history</div></li><li class="half_rhythm"><div>EEG or video EEG if a seizure disorder is suspected; evaluation of the need for antiepileptic drugs</div></li><li class="half_rhythm"><div>Lumbar puncture to measure neurofilament light protein (NFL) in the cerebrospinal fluid (CSF) to follow the disease progression. An increased level of NFL on repeat CSF examinations may suggest faster disease course and thus worse prognosis.</div></li><li class="half_rhythm"><div>Assessment of family and social structure to determine the availability of adequate support systems</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="hdls.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No specific therapy is currently available for ALSP. However, as <i>CSF1R-</i>related ALSP is a microglia-associated neurodegenerative disease it is suggested that hematopoietic stem cell transplantation may have a therapeutic role for this disease [<a class="bk_pop" href="#hdls.REF.eichler.2016.1666">Eichler et al 2016</a>].</p><p>Management is supportive and includes attention to general care and nutritional requirements, antiepileptic drugs for seizures, and antibiotic treatment for general and recurrent infections such as pneumonia or urinary tract infections.</p><p>Other:</p><ul><li class="half_rhythm"><div>L-dopa or other dopaminergic therapies have not been beneficial in individuals with ALSP or in those with an atypical parkinsonian <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, but may be worth trying.</div></li><li class="half_rhythm"><div>Antidepressant medications may be prescribed for depression, although reports to date have demonstrated no long-term benefit.</div></li><li class="half_rhythm"><div>Antipsychotics are in general not recommended due to extrapyramidal side effects, but may be used in aggressive individuals.</div></li><li class="half_rhythm"><div>Anti-seizure medications should be initiated in any individual with seizures and are reported to be beneficial.</div></li></ul></div><div id="hdls.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Social problems (unemployment, divorce, financial troubles, and alcoholism) and suicidal tendencies are often associated with the progression of the disease. Some of the social consequences may be avoided if family members are informed early about the nature of the disorder.</p></div><div id="hdls.Surveillance"><h3>Surveillance</h3><p>Periodic clinical evaluation to monitor for the following is appropriate:</p><ul><li class="half_rhythm"><div>Changes in mobility, communication, and behavior, which could indicate a need to alter care and support systems (wheelchair / personal assistance)</div></li><li class="half_rhythm"><div>Onset of seizures and need for antiepileptic therapy</div></li><li class="half_rhythm"><div>Contractures, which could indicate a need to change medical management and physical therapy</div></li><li class="half_rhythm"><div>Behavioral changes, inappropriate emotions and actions, problems following directions, memory loss, incontinence, which indicate curtailing of independence</div></li><li class="half_rhythm"><div>Difficulties in swallowing or weight loss, which trigger consideration for gastrostomy</div></li><li class="half_rhythm"><div>Need for physical therapy to minimize contractures and maintain locomotion</div></li></ul><p>Longitudinal MRI studies every year can potentially help with prognosis, as during the disease course the more rapid the confluence of patchy or focal T<sub>2</sub>-weighted hyperintensities and the progression of cortical atrophy, the poorer the prognosis appears to be [<a class="bk_pop" href="#hdls.REF.van_gerpen.2008.925">Van Gerpen et al 2008</a>, <a class="bk_pop" href="#hdls.REF.sundal.2012b.566">Sundal et al 2012b</a>].</p></div><div id="hdls.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Use of first-generation neuroleptics, which increase seizure risk and risk of additional parkinsonian signs</div></li><li class="half_rhythm"><div>Treatment agents for multiple sclerosis, as these medications are of no benefit and have major side effects</div></li></ul></div><div id="hdls.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#hdls.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="hdls.Pregnancy_Management"><h3>Pregnancy Management</h3><p>In general, women with epilepsy or a seizure disorder from any cause are at greater risk for mortality during pregnancy than pregnant women without a seizure disorder; use of antiepileptic medication during pregnancy reduces this risk. However, exposure to antiepileptic medication may increase the risk for adverse fetal outcome (depending on the drug used, the dose, and the stage of pregnancy at which medication is taken). Nevertheless, the risk of an adverse outcome to the fetus from antiepileptic medication exposure is often less than that associated with exposure to an untreated maternal seizure disorder. Therefore, use of antiepileptic medication to treat a maternal seizure disorder during pregnancy is typically recommended. Discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place prior to conception. Transitioning to a lower-risk medication prior to pregnancy may be possible [<a class="bk_pop" href="#hdls.REF.sarma.2016.467">Sarma et al 2016</a>].</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="hdls.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="hdls.Genetic_Counseling"><h2 id="_hdls_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="hdls.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>CSF1R</i>-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="hdls.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals with <i>CSF1R-</i>related ALSP have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, although <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> mutation can occur [<a class="bk_pop" href="#hdls.REF.rademakers.2011.200">Rademakers et al 2011</a>, <a class="bk_pop" href="#hdls.REF.kinoshita.2012.115">Kinoshita et al 2012</a>, <a class="bk_pop" href="#hdls.REF.stabile.2016.1565">Stabile et al 2016</a>].</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <i>CSF1R</i>-related ALSP may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In 14 families with <i>CSF1R</i>-related ALSP, one set of monozygotic twins with a <i>de novo</i> pathogenic variant was identified [<a class="bk_pop" href="#hdls.REF.rademakers.2011.200">Rademakers et al 2011</a>]. To date, more than 20 <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) have been reported [<a class="bk_pop" href="#hdls.REF.stabile.2016.1565">Stabile et al 2016</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include the following:</div><ul><li class="half_rhythm"><div>Clinical evaluation and brain MRI</div></li><li class="half_rhythm"><div>Molecular genetic testing for the <i>CSF1R</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></div></li></ul></li><li class="half_rhythm"><div>If the <i>CSF1R</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Germline mosaicism has been reported in an unaffected mother of four sibs with <i>CSF1R</i>-related ALSP [<a class="bk_pop" href="#hdls.REF.eichler.2016.1666">Eichler et al 2016</a>].</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>CSF1R</i>-related ALSP may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> [<a class="bk_pop" href="#hdls.REF.eichler.2016.1666">Eichler et al 2016</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>CSF1R</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for <i>CSF1R</i>-related ALSP because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in one parent.</div></li><li class="half_rhythm"><div>If the <i>CSF1R</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the empiric <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is approximately 1% because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#hdls.REF.eichler.2016.1666">Eichler et al 2016</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>CSF1R</i>-related ALSP has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>CSF1R</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="hdls.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Predictive testing (i.e., testing of asymptomatic at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for at-risk relatives is possible once a <i>CSF1R</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. Such testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals.</div></li><li class="half_rhythm"><div>Potential consequences of such testing (including, but not limited to, socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals with a positive test result) as well as the capabilities and limitations of predictive testing should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing.</div></li></ul><p><b>Predictive testing in minors (i.e., testing of asymptomatic at-risk individuals age &#x0003c;18 years)</b></p><ul><li class="half_rhythm"><div>Predictive testing of minors for adult-onset disorders for which no treatment exists is not considered appropriate. Such testing negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</div></li><li class="half_rhythm"><div>For more information, see the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</div></li></ul><p>In a family with an established diagnosis of <i>CSF1R</i>-related ALSP, it is appropriate to consider testing of symptomatic individuals regardless of age.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="hdls.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CSF1R</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <i>CSF1R</i>-related ALSP are possible.</p></div></div><div id="hdls.Resources"><h2 id="_hdls_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>European Leukodystrophy Association (ELA)</b></div><div>2, rue Mi-les-Vignes</div><div>B.P. 61024</div><div>Laxou Cedex 54521</div><div>France</div><div><b>Phone:</b> 03833093 34</div><div><b>Fax:</b> 03833000 68</div><div><b>Email:</b> ela@ela-asso.com</div><div><a href="http://www.ela-asso.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ela-asso.com</a></div></li><li class="half_rhythm"><div><b>Leukodystrophy Australia</b></div><div>P O Box 2550</div><div>Mount Waverley Victoria 3149</div><div>Australia</div><div><b>Phone:</b> 1800-141-400 (toll free)</div><div><b>Email:</b> info@leuko.org.au</div><div><a href="http://www.leuko.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.leuko.org.au</a></div></li><li class="half_rhythm"><div><b>United Leukodystrophy Foundation (ULF)</b></div><div>224 North Second Street</div><div>Suite 2</div><div>DeKalb IL 60115</div><div><b>Phone:</b> 800-728-5483 (toll-free); 815-748-3211</div><div><b>Fax:</b> 815-748-0844</div><div><b>Email:</b> office@ulf.org</div><div><a href="http://www.ulf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ulf.org</a></div></li><li class="half_rhythm"><div><b>Myelin Disorders Bioregistry Project</b></div><div><b>Email:</b> myelindisorders@cnmc.org</div><div><a href="https://www.chop.edu/research/myelin-disorders-biorepository-project" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myelin Disorders Bioregistry Project</a></div></li></ul></div><div id="hdls.Molecular_Genetics"><h2 id="_hdls_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="hdls.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK100239/table/hdls.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hdls.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_hdls.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_hdls.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_hdls.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_hdls.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_hdls.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_hdls.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1436" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CSF1R</i></a></td><td headers="hd_b_hdls.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1436" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q32</a></td><td headers="hd_b_hdls.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P07333" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Macrophage colony-stimulating factor 1 receptor</a></td><td headers="hd_b_hdls.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CSF1R" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CSF1R</a></td><td headers="hd_b_hdls.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CSF1R[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CSF1R</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="hdls.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="hdls.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (<a href="/omim/164770,221820" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK100239/table/hdls.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hdls.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/164770" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">164770</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLONY-STIMULATING FACTOR 1 RECEPTOR; CSF1R</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/221820" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">221820</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS; HDLS</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>CSF1R</i> comprises 22 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK100239/#hdls.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> No normal variants have been reported.</p><p><b>Pathogenic variants.</b> To date, more than 50 different <i>CSF1R</i> pathogenic variants including <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants have been reported. All identified pathogenic variants are located in exons 12 to 22, which encode the intracellular tyrosine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the receptor [<a class="bk_pop" href="#hdls.REF.rademakers.2011.200">Rademakers et al 2011</a>, <a class="bk_pop" href="#hdls.REF.stabile.2016.1565">Stabile et al 2016</a>, <a class="bk_pop" href="#hdls.REF.konno.2017.37">Konno et al 2017</a>].</p><div id="hdls.T.csf1r_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>CSF1R</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK100239/table/hdls.T.csf1r_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hdls.T.csf1r_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hdls.T.csf1r_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_hdls.T.csf1r_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_hdls.T.csf1r_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_hdls.T.csf1r_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2512G&#x0003e;C</td><td headers="hd_h_hdls.T.csf1r_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val838Leu</td><td headers="hd_h_hdls.T.csf1r_pathogenic_variants_discuss_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_005211.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005211<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_005202.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005202<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_hdls.T.csf1r_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2562T&#x0003e;A</td><td headers="hd_h_hdls.T.csf1r_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn854Lys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The CSF1R protein is a cell-surface receptor primarily for the cytokine CSF-1, which regulates the survival, proliferation, differentiation, and function of mononuclear phagocytic cells, including microglia of the central nervous system. CSF1R comprises a highly glycosylated extracellular ligand-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, a transmembrane domain, and an intracellular tyrosine kinase domain. Binding of CSF-1 to its receptor (CSF1R) results in the formation of receptor homodimers and subsequent autophosphorylation of several tyrosine residues in the cytoplasmic domain. CSF1R autophosphorylation precedes CSF1R-dependent phosphorylation of several proteins, including the phosphatase SHP-1 and the kinases Src, PLC-&#x003b3;, PI(3)K, Akt, and Erk [<a class="bk_pop" href="#hdls.REF.rademakers.2011.200">Rademakers et al 2011</a>].</p><p>In the brain, CSF1R is predominately expressed in microglial cells. The link between pathogenic variants in <i>CSF1R</i> and the neuronal/glial dysfunction remains to be elucidated.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>CSF1R</i> pathogenic variants that cause ALSP affect the kinase activity and potentially the phosphorylation of downstream targets.</p></div><div id="hdls.References"><h2 id="_hdls_References_">References</h2><div id="hdls.Published_GuidelinesConsensus_State"><h3>Published Guidelines/Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="hdls.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 10-16-18. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2017. Accessed 10-16-18.</div></li></ul></div><div id="hdls.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.bender.2014.2351">Bender B, Klose U, Lindig T, Biskup S, N&#x000e4;gele T, Sch&#x000f6;ls L, Karle KN. Imaging features in conventional MRI, spectroscopy and diffusion weighted images of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). <span><span class="ref-journal">J Neurol. </span>2014;<span class="ref-vol">261</span>:2351–9.</span> [<a href="/pubmed/25239393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25239393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.eichler.2016.1666">Eichler FS, Li J, Guo Y, Caruso PA, Bjonnes AC, Pan J, Booker JK, Lane JM, Tare A, Vlasac I, Hakonarson H, Gusella JF, Zhang J, Keating BJ, Saxena R. CSF1R mosaicism in a family with hereditary diffuse leukoencephalopathy with spheroids. <span><span class="ref-journal">Brain. </span>2016;<span class="ref-vol">139</span>:1666–72.</span> [<a href="/pmc/articles/PMC4892751/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4892751</span></a>] [<a href="/pubmed/27190017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27190017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.karle.2013.2039">Karle KN, Biskup S, Sch&#x000fc;le R, Schweitzer KJ, Kr&#x000fc;ger R, Bauer P, Bender B, N&#x000e4;gele T, Sch&#x000f6;ls L. De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">81</span>:2039–44.</span> [<a href="/pubmed/24198292" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24198292</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.kinoshita.2012.115">Kinoshita M, Yoshida K, Oyanagi K, Hashimoto T, Ikeda S. Hereditary diffuse leukoencephalopathy with axonal spheroids caused by R782H mutation in CSF1R: case report. <span><span class="ref-journal">J Neurol Sci. </span>2012;<span class="ref-vol">318</span>:115–8.</span> [<a href="/pubmed/22503135" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22503135</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.konno.2014.139">Konno T, Tada M, Tada M, Koyama A, Nozaki H, Harigaya Y, Nishimiya J, Matsunaga A, Yoshikura N, Ishihara K, Arakawa M, Isami A, Okazaki K, Yokoo H, Itoh K, Yoneda M, Kawamura M, Inuzuka T, Takahashi H, Nishizawa M, Onodera O, Kakita A, Ikeuchi T. Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:139–48.</span> [<a href="/pmc/articles/PMC3937843/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3937843</span></a>] [<a href="/pubmed/24336230" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24336230</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.konno.2017.37">Konno T, Yoshida K, Mizuno T, Kawarai T, Tada M, Nozaki H, Ikeda SI, Nishizawa M, Onodera O, Wszolek ZK, Ikeuchi T. Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation. <span><span class="ref-journal">Eur J Neurol. </span>2017;<span class="ref-vol">24</span>:37–45.</span> [<a href="/pmc/articles/PMC5215554/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5215554</span></a>] [<a href="/pubmed/27680516" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27680516</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.lakshmanan.2017.e135">Lakshmanan R, Adams ME, Lynch DS, Kinsella JA, Phadke R, Schott JM, Murphy E, Rohrer JD, Chataway J, Houlden H, Fox NC, Davagnanam I. Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy. <span><span class="ref-journal">Neurol Genet. </span>2017;<span class="ref-vol">3</span>:e135.</span> [<a href="/pmc/articles/PMC5312114/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5312114</span></a>] [<a href="/pubmed/28243630" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28243630</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.levin.2014.113">Levin J, Tiedt S, Arzberger T, Biskup S, Schuberth M, Stenglein-Krapf G, Kreth FW, H&#x000f6;gen T, la Foug&#x000e8;re C, Linn J, van der Knaap MS, Giese A, Kretzschmar HA, Danek A. Diffuse leukoencephalopathy with spheroids: biopsy findings and a novel mutation. <span><span class="ref-journal">Clin Neurol Neurosurg. </span>2014;<span class="ref-vol">122</span>:113–5.</span> [<a href="/pubmed/24908228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24908228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.lynch.2016.512">Lynch DS, Jaunmuktane Z, Sheerin UM, Phadke R, Brandner S, Milonas I, Dean A, Bajaj N, McNicholas N, Costello D, Cronin S, McGuigan C, Rossor M, Fox N, Murphy E, Chataway J, Houlden H. Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy series. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2016;<span class="ref-vol">87</span>:512–9.</span> [<a href="/pmc/articles/PMC4853550/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4853550</span></a>] [<a href="/pubmed/25935893" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25935893</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.nicholson.2013.1033">Nicholson AM, Baker MC, Finch NA, Rutherford NJ, Wider C, Graff-Radford NR, Nelson PT, Clark HB, Wszolek ZK, Dickson DW, Knopman DS, Rademakers R. CSF1R mutations link POLD and HDLS as a single disease entity. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:1033–40.</span> [<a href="/pmc/articles/PMC3653204/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3653204</span></a>] [<a href="/pubmed/23408870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23408870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.rademakers.2011.200">Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Cairns NJ, Ghetti B, Spina S, Garbern J, Tselis AC, Uitti R, Das P, Van Gerpen JA, Meschia JF, Levy S, Broderick DF, Graff-Radford N, Ross OA, Miller BB, Swerdlow RH, Dickson DW, Wszolek ZK. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">44</span>:200–5.</span> [<a href="/pmc/articles/PMC3267847/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3267847</span></a>] [<a href="/pubmed/22197934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22197934</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.sarma.2016.467">Sarma AK, Khandker N, Kurczewski L, Brophy GM. Medical management of epileptic seizures: challenges and solutions. <span><span class="ref-journal">Neuropsychiatr Dis Treat. </span>2016;<span class="ref-vol">12</span>:467–85.</span> [<a href="/pmc/articles/PMC4771397/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4771397</span></a>] [<a href="/pubmed/26966367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26966367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.schuberth.2014.465">Schuberth M, Levin J, Sawalhe D, Schwarzkopf R, von Baumgarten L, Ertl-Wagner B, Rominger A, Arzberger T, Kretzschmar HA, Frob&#x000f6;se T, Diehl-Schmid J, Biskup S, Danek A. Hereditary diffuse leukencephalopathy with spheroids: a microgliopathy due to CSF1 receptor impairment. <span><span class="ref-journal">Nervenarzt. </span>2014;<span class="ref-vol">85</span>:465–70.</span> [<a href="/pubmed/24706185" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24706185</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.stabile.2016.1565">Stabile C, Taglia I, Battisti C, Bianchi S, Federico A. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): update on molecular genetics. <span><span class="ref-journal">Neurol Sci. </span>2016;<span class="ref-vol">37</span>:1565–9.</span> [<a href="/pubmed/27338940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27338940</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.sundal.2015.328">Sundal C, Baker M, Karrenbauer V, Gustavsen M, Bedri S, Glaser A, Myhr KM, Haugarvoll K, Zetterberg H, Harbo H, Kockum I, Hillert J, Wszolek Z, Rademakers R, Andersen O. Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. <span><span class="ref-journal">Eur J Neurol. </span>2015;<span class="ref-vol">22</span>:328–33.</span> [<a href="/pmc/articles/PMC4289423/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4289423</span></a>] [<a href="/pubmed/25311247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25311247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.sundal.2012a.67">Sundal C, Ekholm S, Nordborg C, J&#x000f6;nsson L, B&#x000f6;rjesson-Hanson A, Lind&#x000e9;n T, Zetterberg H, Viitanen M, Andersen O. Update of the original HDLS kindred: divergent clinical courses. <span><span class="ref-journal">Acta Neurol Scand. </span>2012a;<span class="ref-vol">126</span>:67–75.</span> [<a href="/pubmed/22098561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22098561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.sundal.2012b.566">Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, Heckman MG, Uitti RJ, Josephs KA, Baker M, Andersen O, Rademakers R, Dickson DW, Broderick D, Wszolek ZK. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. <span><span class="ref-journal">Neurology. </span>2012b;<span class="ref-vol">79</span>:566–74.</span> [<a href="/pmc/articles/PMC3413763/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3413763</span></a>] [<a href="/pubmed/22843259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22843259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.van_gerpen.2008.925">Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:925–9.</span> [<a href="/pmc/articles/PMC2843529/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2843529</span></a>] [<a href="/pubmed/18794495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18794495</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hdls.REF.wider.2009.1953">Wider C, Van Gerpen JA, Dearmond S, Shuster EA, Dickson DW, Wszolek ZK. Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:1953–9.</span> [<a href="/pmc/articles/PMC2843560/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2843560</span></a>] [<a href="/pubmed/19487654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19487654</span></a>]</div></li></ul></div></div><div id="hdls.Chapter_Notes"><h2 id="_hdls_Chapter_Notes_">Chapter Notes</h2><div id="hdls.Acknowledgments"><h3>Acknowledgments</h3><p>Dr Wszolek was partially supported by National Institute of Health/National Institute of Neurological Disorders and Stroke [P50-NS072187] , Mayo Clinic Center for Regenerative Medicine, Mayo Clinic Center for Individualized Medicine, Mayo Clinic Neuroscience Focused Research Team (Cecilia and Dan Carmichael Family Foundation, and the James C. and Sarah K. Kennedy Fund for Neurodegenerative Disease Research at Mayo Clinic in Florida) and philanthropic gifts from Carl Edward Bolch, Jr., and Susan Bass Bolch, The Sol Goldman Charitable Trust, and Donald G and Jodi P Heeringa.</p><p>Dr Sundal is partially supported by a grant from NHR (Society of the Neurologically Handicapped), Stockholm and Gothenburg, Sweden.</p></div><div id="hdls.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>5 October 2017 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 December 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 January 2013 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for <i>CSF1R</i> available clinically</div></li><li class="half_rhythm"><div>30 August 2012 (me) Review posted live</div></li><li class="half_rhythm"><div>23 May 2012 (zkw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK100239</span><span class="label">PMID: <a href="/pubmed/22934315" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">22934315</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/col4a1-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/caffey/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK100239&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK100239/?report=reader">PubReader</a></li><li><a href="/books/NBK100239/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK100239" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK100239" style="display:none" title="Cite this Page"><div class="bk_tt">Sundal C, Wszolek ZK. CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia. 2012 Aug 30 [Updated 2017 Oct 5]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK100239/pdf/Bookshelf_NBK100239.pdf">PDF version of this page</a> (465K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#hdls.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#hdls.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#hdls.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#hdls.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#hdls.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#hdls.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#hdls.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#hdls.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#hdls.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#hdls.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#hdls.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1436[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CSF1R</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK100239+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2972886" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2972886" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2972886" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2972886" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25563800" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia linked CSF1R mutation: Report of four Korean cases.</a><span class="source">[J Neurol Sci. 2015]</span><div class="brieflinkpop offscreen_noflow">Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia linked CSF1R mutation: Report of four Korean cases.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kim EJ, Shin JH, Lee JH, Kim JH, Na DL, Suh YL, Hwang SJ, Lee JH, Lee YM, Shin MJ, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurol Sci. 2015 Feb 15; 349(1-2):232-8. Epub 2014 Dec 20.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29122458" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD).</a><span class="source">[J Clin Neurosci. 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Adams SJ, Kirk A, Auer RN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Clin Neurosci. 2018 Feb; 48:42-49. Epub 2017 Nov 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27749956" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.</a><span class="source">[JAMA Neurol. 2016]</span><div class="brieflinkpop offscreen_noflow">Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lynch DS, Zhang WJ, Lakshmanan R, Kinsella JA, Uzun GA, Karbay M, Tüfekçioglu Z, Hanagasi H, Burke G, Foulds N, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">JAMA Neurol. 2016 Dec 1; 73(12):1433-1439. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27680516" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.</a><span class="source">[Eur J Neurol. 2017]</span><div class="brieflinkpop offscreen_noflow">Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Konno T, Yoshida K, Mizuno T, Kawarai T, Tada M, Nozaki H, Ikeda SI, Nishizawa M, Onodera O, Wszolek ZK, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Neurol. 2017 Jan; 24(1):37-45. Epub 2016 Sep 29.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23052599" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation.</a><span class="source">[J Neurol. 2013]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kleinfeld K, Mobley B, Hedera P, Wegner A, Sriram S, Pawate S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurol. 2013 Feb; 260(2):558-71. Epub 2012 Sep 30.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=22934315" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=22934315" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041a8edd21425a256dc4d1">CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmente...</a><div class="ralinkpop offscreen_noflow">CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:27:26-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88147FE04109D100000000048401AF&amp;ncbi_session=CE88147FE041A8D1_1156SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK100239%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK100239&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK100239/&amp;ncbi_pagename=CSF1R-Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88147FE041A8D1_1156SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>